GO:0031343 positive regulation of cell killing: Immune Cytotoxicity Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031343 (positive regulation of cell killing) describes any biological process that activates or increases the frequency, rate, or extent of cell killing.
• It is a biological_process term that sits upstream of cell death execution and is central to immune surveillance, immunotherapy, and host defense.
• Key effector mechanisms include cytotoxic granule exocytosis, death receptor signaling (FAS/FASLG), and cytokine-driven activation of killer cells.
• Tumor immune evasion frequently dampens positive regulation of cell killing through checkpoint molecules such as PD-L1 and metabolic axes like kynurenine/Siglec-15.
• CRISPR knockout, knock-in, point-mutation, and overexpression models are essential to dissect which genes causally enhance or suppress cell killing.
• The term is highly relevant to cancer immunotherapy, autoimmune cytotoxicity, and infectious disease research.
Description
Positive regulation of cell killing (GO:0031343) is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate, or extent of cell killing. It captures the upstream regulatory events that license, amplify, or sustain the destruction of target cells, rather than the execution steps of apoptosis or necrosis themselves. This term is therefore central to understanding how cytotoxic lymphocytes, natural killer (NK) cells, and other killer populations are activated and directed toward infected, transformed, or otherwise harmful cells. In cancer immunology, the balance between positive and negative regulation of cell killing determines whether a tumor is eliminated or escapes immune control. For researchers, GO:0031343 provides a structured framework to annotate genes and pathways that enhance cytotoxicity, from T-cell receptor (TCR) signaling strength to cytokine and checkpoint modulation. Because many immunotherapies aim to restore or boost cell killing, this term is also a practical entry point for target discovery and CRISPR-based functional validation.
positive regulation of cell killing At A Glance
| GO ID | GO:0031343 |
|---|---|
| GO term | positive regulation of cell killing |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of cell killing. |
| Synonym | activation of cell killing; stimulation of cell killing; up regulation of cell killing; up-regulation of cell killing; upregulation of cell killing |
| Major function | Upstream activation and amplification of cytotoxic effector programs that eliminate target cells. |
| Related processes | T cell activation, NK cell cytotoxicity, death receptor signaling, cytokine signaling, immune checkpoint regulation. |
| Disease relevance | Cancer immunotherapy, autoimmune cytotoxicity, infectious disease, transplant rejection. |
| Research methods | CRISPR knockout/knock-in, cytotoxicity assays, flow cytometry, RNA-seq, proteomics. |
What Is GO:0031343?
In plain terms, GO:0031343 describes the set of processes that turn up the volume on cell killing. According to the QuickGO definition, it is any process that activates or increases the frequency, rate, or extent of cell killing. This includes signals that prime killer cells, promote their engagement with targets, or enhance the efficiency of cytotoxic effector mechanisms. It is a positive regulatory term, meaning it is distinct from the cell killing process itself and from negative regulation of cell killing.
Why Is positive regulation of cell killing Important in Cell Biology?
Positive regulation of cell killing is a cornerstone of immune defense and immunotherapy. It determines whether cytotoxic T cells and NK cells can effectively eliminate cancer cells, infected cells, or allogeneic targets. Dysregulation of this process contributes to tumor immune evasion, autoimmunity, and chronic infection. Understanding the genes and signals that positively regulate cell killing is therefore essential for developing strategies to enhance cancer immunotherapy, control autoimmune damage, and design targeted cell-killing therapeutics.
• Central to cancer immunotherapy: boosting positive regulation of cell killing can overcome tumor immune evasion.
• Critical for NK cell-mediated control of metastasis and cancer stem cells.
• Underlies T cell-mediated cytotoxicity and the efficacy of adoptive cell therapies.
• Involved in autoimmune diseases where excessive cell killing damages healthy tissues.
• Key to host defense against intracellular pathogens and virus-infected cells.
• Provides a mechanistic framework for interpreting CRISPR screens aimed at immune resistance.
• Guides development of bispecific antibodies and engagers that redirect killer cells.
• Links metabolic and checkpoint pathways to cytotoxic function.
• Enables functional annotation of genes that enhance or suppress cell killing.
• Supports biomarker discovery for immunotherapy response.
What Happens During positive regulation of cell killing?
Activation of killer cells
In simple terms: Killer cells need to be switched on before they can destroy targets.
Positive regulation of cell killing begins with the activation of cytotoxic lymphocytes such as CD8+ T cells and NK cells. T cell activation requires recognition of antigen-MHC complexes by the TCR, and the strength of this signal shapes subsequent cytotoxic capacity. NK cell activation is governed by a balance of activating and inhibitory receptors, and positive regulation tips this balance toward killing. Cytokines such as IL-2 and IL-15 further amplify killer cell activation and proliferation.
Recognition and engagement of target cells
In simple terms: The killer cell must find and physically connect with its target.
Once activated, killer cells migrate to and engage target cells. This involves adhesion molecules, integrins, and the formation of an immunological synapse. TCR signal strength influences the efficiency of target recognition and the subsequent killing response. In NK cells, missing-self recognition and stress-induced ligands promote engagement with transformed cells.
Delivery of cytotoxic effectors
In simple terms: The killer cell releases poisons or death signals onto the target.
Engagement triggers directed exocytosis of cytotoxic granules containing perforin and granzymes, which induce target cell death. Alternatively, death receptor pathways such as FAS-FASLG mediate killing. Positive regulation of cell killing enhances the frequency and efficiency of these effector delivery mechanisms.
Amplification by cytokines and costimulation
In simple terms: Additional signals make the killing stronger and longer-lasting.
Costimulatory molecules (e.g., CD28, 4-1BB) and cytokines sustain and amplify cytotoxic programs. These signals increase the rate and extent of cell killing, aligning with the GO:0031343 definition. Metabolic fitness, including lipid and amino acid metabolism, also supports sustained killing capacity.
Overcoming negative regulation
In simple terms: Removing brakes on killer cells increases cell killing.
Positive regulation of cell killing often involves counteracting inhibitory signals. Checkpoint molecules such as PD-L1 engage PD-1 to suppress killing, and their downregulation or blockade enhances cytotoxicity. Metabolic enzymes like USP2 stabilize PD-L1, and inhibiting USP2 promotes tumor immune evasion reversal. Similarly, the kynurenine/Siglec-15 axis suppresses T cell killing, and targeting this axis restores positive regulation.
Key Genes Involved in GO:0031343 positive regulation of cell killing
The following genes and proteins are central to positive regulation of cell killing, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD8A | T cell co-receptor for MHC class I | Defines cytotoxic T cell identity and killing capacity |
| GZMB | Granzyme B serine protease | Effector molecule for target cell apoptosis |
| PRF1 | Perforin pore-forming protein | Required for granzyme delivery |
| FASLG | Fas ligand | Death receptor-mediated killing |
| FAS | Death receptor | Mediates off-target tumor killing |
| PDCD1 | PD-1 checkpoint receptor | Negative regulator of T cell killing |
| CD274 | PD-L1 ligand | Engages PD-1 to suppress killing |
| USP2 | Deubiquitinase stabilizing PD-L1 | Promotes immune evasion |
| ILF3 | RNA-binding protein regulating PD-L1 | Target of simvastatin to induce ferroptosis |
| SIGLEC15 | Immune checkpoint ligand | Kynurenine-driven immune escape |
| IFNG | Interferon gamma | Enhances antigen presentation and killing |
| TNF | Tumor necrosis factor | Promotes cytotoxicity and inflammation |
| NKG7 | NK cell granule protein | Regulates cytotoxic granule exocytosis |
| KLRD1 | CD94 NK receptor | NK cell activation and killing |
| IL2 | T cell growth factor | Amplifies cytotoxic T cell responses |
| IL15 | NK and T cell cytokine | Promotes survival and killing |
| CD28 | Costimulatory receptor | Enhances TCR-driven killing |
| TNFRSF9 | 4-1BB costimulatory receptor | Boosts cytotoxic T cell activity |
How Is positive regulation of cell killing Regulated?
Positive regulation of cell killing is tightly controlled at multiple levels. TCR signal strength determines whether T cells become effective killers or dysfunctional. Checkpoint pathways, including PD-1/PD-L1, deliver inhibitory signals that suppress killing, and their regulation by deubiquitinases such as USP2 modulates tumor immune evasion. Metabolic pathways, such as the kynurenine/Siglec-15 axis, also regulate cytotoxic capacity. Additionally, cytokines like IL-2 and IL-15 positively regulate killing by promoting survival and effector differentiation. Pharmacological agents, such as simvastatin, can inhibit PD-L1 via ILF3 and induce ferroptosis, indirectly enhancing cell killing.
positive regulation of cell killing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD274 | Cancer immune evasion via PD-L1 | Knockout in tumor cell lines to assess T cell killing |
| USP2 | Tumor immune evasion | Overexpression and knockout in cancer cells |
| SIGLEC15 | Head and neck squamous cell carcinoma immune escape | Knockout in HNSCC cells to test kynurenine axis |
| FAS | Off-target killing in immunotherapy | Point mutation to disrupt Fas signaling |
| NKG7 | Metastatic dormancy in breast cancer | Knockout in NK cells to assess cytotoxicity |
Cancer and tumor immune evasion
Positive regulation of cell killing is often suppressed in the tumor microenvironment. Upregulation of PD-L1 on tumor cells engages PD-1 on T cells to inhibit killing, and USP2 stabilizes PD-L1 to promote evasion. Metabolic reprogramming, such as the kynurenine/Siglec-15 axis in head and neck squamous cell carcinoma, further dampens T cell cytotoxicity. Conversely, enhancing positive regulation through checkpoint blockade or metabolic intervention restores tumor cell killing. NK cells also regulate breast cancer stem cells and metastatic dormancy, highlighting the role of positive regulation in controlling metastasis.
Autoimmunity and off-target cytotoxicity
Excessive positive regulation of cell killing can lead to autoimmune tissue damage. Fas-mediated off-target tumor killing in T-cell immunotherapy illustrates how cytotoxic mechanisms can inadvertently harm healthy cells. Understanding the regulators of cell killing is therefore critical for designing safer immunotherapies.
Infectious disease
Effective killing of infected cells is essential for host defense. T cells and NK cells positively regulate cell killing to eliminate virus-infected cells, and impairments in this process can lead to chronic infection.
From positive regulation of cell killing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X enhance T cell-mediated killing? | CRISPR knockout in T cells followed by cytotoxicity assay |
| Does a point mutation in FAS alter off-target killing? | Point-mutation knock-in in tumor cells |
| Can overexpression of a costimulatory receptor boost killing? | Overexpression of TNFRSF9 in T cells |
| Does PD-L1 knockout increase tumor cell killing? | Knockout of CD274 in cancer cell lines |
| Does USP2 inhibition restore immune evasion? | Knockout or small-molecule inhibition in tumor cells |
| Does Siglec-15 knockout affect kynurenine-mediated escape? | Knockout in HNSCC cells |
How to Study the positive regulation of cell killing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cytotoxicity assay | Target cell death | Assess positive regulation of cell killing |
| CRISPR knockout screen | Gene requirement for killing | Identify positive regulators |
| RNA-seq | Transcriptional changes | Map activation-induced gene expression |
| Proteomics | Protein abundance and modifications | Identify signaling changes |
| Flow cytometry | Effector molecule expression | Quantify granzyme B and perforin |
| Imaging | Synapse formation and killing | Visualize cell-cell interactions |
| Metabolic assays | Metabolic flux | Link metabolism to killing |
| Checkpoint blockade assays | PD-L1/PD-1 inhibition | Test restoration of killing |
Cytotoxicity assays
Standard chromium release or flow cytometry-based killing assays measure the frequency and extent of target cell death. These assays are used to quantify positive regulation of cell killing after genetic or pharmacological manipulation.
CRISPR screens
Genome-wide CRISPR knockout or activation screens identify genes that positively or negatively regulate cell killing. Such screens have revealed regulators of immune evasion and cytotoxicity.
Transcriptomics and proteomics
RNA-seq and proteomics can map expression changes in killer cells and targets during activation. These methods help identify pathways that enhance cell killing.
Flow cytometry and imaging
Flow cytometry quantifies effector molecule expression (e.g., granzyme B, perforin) and degranulation. Imaging can visualize immunological synapse formation and target cell death.
How CRISPR Can Be Used to Study GO:0031343 positive regulation of cell killing
Knockout
CRISPR knockout is used to delete genes such as CD274, USP2, or SIGLEC15 to determine whether they suppress positive regulation of cell killing. Loss of these genes typically enhances T cell-mediated killing.
Point Mutation
Point mutations can be introduced into genes like FAS to dissect signaling domains required for off-target killing. This helps distinguish killing mechanisms.
Knock-in
Knock-in of reporters or tags (e.g., fluorescent tags on GZMB) allows real-time tracking of cytotoxic granule release and killing dynamics.
Overexpression
Overexpression of costimulatory receptors (e.g., TNFRSF9) or cytokines (e.g., IL2) can boost positive regulation of cell killing and is used to engineer more potent killer cells.
How EDITGENE Supports positive regulation of cell killing Research
Researchers studying positive regulation of cell killing-related genes often need to determine whether a candidate gene is causally involved in enhancing or suppressing cytotoxicity. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cell killing research.
Frequently Asked Questions About positive regulation of cell killing
What is GO:0031343 positive regulation of cell killing?
GO:0031343 is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate, or extent of cell killing.
What genes are involved in positive regulation of cell killing?
Key genes include CD8A, GZMB, PRF1, FASLG, FAS, PDCD1, CD274, USP2, SIGLEC15, IFNG, and TNF, among others.
How is positive regulation of cell killing measured?
It is measured using cytotoxicity assays, flow cytometry for effector molecules, and CRISPR screens.
What diseases are associated with positive regulation of cell killing?
Cancer, autoimmune diseases, and infectious diseases are associated with dysregulation of this process.
How do cancer cells evade positive regulation of cell killing?
They upregulate checkpoint molecules like PD-L1 and metabolic pathways such as kynurenine/Siglec-15 to suppress cytotoxic T cell activity.
What is the role of NK cells in positive regulation of cell killing?
NK cells positively regulate cell killing by recognizing and destroying transformed or infected cells, and they can control metastatic dormancy.
Can CRISPR be used to study positive regulation of cell killing?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect genes that regulate cell killing.
What is the difference between cell killing and positive regulation of cell killing?
Cell killing is the execution process, while positive regulation of cell killing refers to upstream signals that activate or enhance it.
Which cytokines enhance positive regulation of cell killing?
IL-2 and IL-15 are key cytokines that amplify cytotoxic lymphocyte responses.
How does PD-L1 affect positive regulation of cell killing?
PD-L1 engages PD-1 to deliver inhibitory signals that suppress T cell killing, thereby negatively regulating the process.
Conclusion
GO:0031343 positive regulation of cell killing is a fundamental biological process that governs the activation and amplification of cytotoxic effector mechanisms. It is central to cancer immunotherapy, host defense, and autoimmune pathology. Understanding its genetic and molecular regulators provides a roadmap for developing novel therapeutics that enhance tumor cell killing while minimizing off-target damage. CRISPR-based models and functional screens are indispensable tools for dissecting this process and translating findings into clinical applications.
References
- 1. Sun L et al.. 2023. T cells in health and disease.. Signal Transduct Target Ther 8(1):235 PMID: 37332039
- 2. Bushnell GG et al.. 2024. Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy.. Cancer Res 84(20):3337-3353 PMID: 39106452
- 3. Upadhyay R et al.. 2021. A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.. Cancer Discov 11(3):599-613 PMID: 33334730
- 4. Shakiba M et al.. 2022. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.. J Exp Med 219(2) PMID: 34935874
- 5. Kuang Z et al.. 2023. USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1.. Cell Death Differ 30(10):2249-2264 PMID: 37670038
- 6. Zhang XY et al.. 2024. Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape.. Cancer Commun (Lond) 44(6):670-694 PMID: 38734931
- 7. Syed YY. 2025. Catumaxomab: First Approval.. Drugs 85(7):957-963 PMID: 40304879
- 8. Sun D et al.. 2025. Simvastatin inhibits PD-L1 via ILF3 to induce ferroptosis in gastric cancer cells.. Cell Death Dis 16(1):208 PMID: 40140647
